2013 annual financial data
Evogene 2013 Operating margin
Direct answer
Operating margin was -49.6%.
Operating income was -8,721,000 USD and net income was -8,878,000 USD.
Operating cash flow was -5,270,000 USD.
Get free Evogene email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,581,000 USD
- Operating income
- -8,721,000 USD
- Net income
- -8,878,000 USD
- Operating cash flow
- -5,270,000 USD